 Application monoclonal antibody prostate biopsies fraction human prostatic carcinoma feasibility monoclonal antibody proliferation marker human prostatic carcinoma aspiration core biopsy specimens patients prostate cancer prostatic index mean cytological smears mean frozen sections histological core biopsies significant correlation percentage cells positive histological tumor differentiation patients benign prostatic hyperplasia index mean mean cytological histological material differences observed index benign malignant prostatic tissues statistical clinical significance Nine patients underwent endocrine treatment radiotherapy followup protocol staining procedure obtained cytological aspiration biopsies month start therapy significant decrease index initial values months proliferative fraction decrease marker monoclonal antibody reliable method proliferative cell fraction human prostate cancer